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Abstract 
SSFe-transferrin and s9Fe-ferritin were injected simultaneously in rats 
and storage iron release by the hepatocyte was calculated from the 
cumulative incorporation of the two isotopes in the red cell mass over 2 
weeks. About 6 % of hepatocyte storage iron was released daily in normal 
rats, but a non-mobilizable pool was identified in iron overload. Iron 
release was regulated by the rate of erythropoiesis and iron status of the 
animal, while acute inflammation blocked iron release only transiently. 
Introduction 
Hepatocyte iron release to the plasma is less well characterized than iron 
uptake by the liver (1). Two phases of iron release can be distinguished, 
i.e. (a) an immediate release during the initial processing of 
transferrin, hemoglobin, ferritin, or "freell iron (early release, ER), and 
(b) iron release from stores (late release, LR). We present the results 
of studies of storage iron release in normal rats and animais with various 
disorders of iron status and erythropoiesis, using s9Fe-labelled ferritin 
as a selective tag of hepatocytes (2,3,4). 
Trace Element Analytîcal Chemistry in Medicine and Biology 
© 1988 Walter de Gruyter & Co., Berlin· New York - Printed in Germany 
541 
56a. Flynn, A., S.I. Miller, S.S. Martier, N.L. Goldern, R.J. 
SakaI, and B.e. Del Villano. 1981. Lancet.l, 572-575. 
57. Turnlund, J.R., C.A. Swanson, and J.C. King. 1983. J. 
Nutr. ~, 2346-2352. 
58. Cornmittee on Dietary Allowances, Food and Nutrition Board. 
1980. Recommended Dietary Allowances, 9th Edition. 
National Academy of Sciences, Washington DG, USA. 
59. Freidman, S., C. Baharg, B. Eckerling, and B. Gans. 
1969. Obstet. Gynecol. 11, 189-194. 
60. Schenker, J.G., E. Jiengies, and W.Z. Polishiek. 1969. 
Am. J. Obstet. Gynecol. 105, 933-937. 
61. Q' Leary, J .A., G.S. Novalis, and G.J. Vosburgh. 1966. 
Obstet. Gynecol. ~, 112-117. 
62. Mirzakarimov, M.G. 1953. Akush. Ginekol. l, 55-85. 
63. Rasuli, 2.M. 1963. Akush. Ginekol. 1.2., 63-66. 
64. Linares, A., 
Diaz-Perez. 
J.J. Larranz, J. Rodrlguez-Aluscon, and J.L. 
1979. Lancet~, 43-44. 
65. Mjolnerod, O.K., K. Rasmus~en, S.A. Dommerad, and S.T. 
Gjeraldsen. 1971. Lancet~, 673-675. 
66. Henkin, R.I., J.R. Marshall, and S. Meret. 1971. Am. J. 
Obstet. Gynecol. 103, 320-344. 
67. Swanson, C.A., D.C. Reames, C. Veillon, J.C. King, and 
O.A. Levander. 1983. Am. J. Clin. Nutr. 38, 169-180. 
68. Rudolph, N., and Wong, S.L. 1978. Ped. Res. g, 789-792. 
69. Behne, D., and W. Walters. 1979. J. Clin. Chem. Clin. 
Biochem. 11, 133-135. 
70. Levander, O.A., P.B. Moser, and V.C. Morris. 1987. Am. 
J. Clin. Nutr. i§., 694-698. 
71. Butler, J.A., P.D. Whanger, M.J. Tripp. 1982. Am. J. 
Clin. Nutr. ~, 15-23. 
72. Anderson, R.A. 1986. Clin. Physiol. Biochem. ~, 31-41. 
73. Davidson, I.W.F., and R.C. Burt. 1973. Am. J. Obstet. 
Gynecol. ~, 601-608. 
74. Hambidge, K.M., and W. Dioegemueller. 1974. Obstet. 
Gynecol. ii, 666-672. 
75. Mahalko, J.R., and M. Bennion. 
~, 1069-1072. 
1976. Am. J. Clin. Nutr. 
76. Krebs, 
1985. 
N.F., K.M. Hambidge, M.A. Jacobs, and J.O. Rasback. 
Am. J. Clin. Nutr . .::...l., 560-570. 
77. Vuori, E., S.M. Makinen, R.Kara, and P. Kuitunen. 1980. 
Am. J. Clin. Nutr.ll, 227-231. 
78. Mannan, S., and M.F. Picciano. 
i§., 95-100. 
1987. Am. J. Clin. Nutr. 
~3 
Methods 
Rat transferrin was purified by saturating plasma transferrin with ferrous 
sulfate, followed by ammonium sulfate precipitation, ion-exchange 
chromatography using a DEAE Sephacel column and gel chromatography using a 
S-200 Sephacryl column. Apotransferrin was prepared by incubating 
diferric transferrin with desferrioxamine, which was removed afterwards by 
ultrafiltration. Labeling of apotransferrin with 5sFe ferrous sulfate was 
achieved in the presence of 0.05 M Na bicarbonate and 0.1 M Tris/Hel. The 
transferrin solution was brought ta the point of saturation by adding cold 
ferrous sulfate. Ferritin was purified fram rat liver by heating at 75°C 
for 10 minutes, ammonium sulfate precipitation, gel chromatography uslng a 
Sepharose 6B column, and ultracentrifugation (3). In vitro tagging of 
ferritin was achieved by adding s9FeSO~ to a normal rat ferrltin 
preparation in 0.1 M Hepes buffer (pH 7.5). The labelled ferritin was 
purified by ion-exchange chromatography using a DEAE Sephacel column (3). 
Male Sprague-Dawley rats 8 to 10 weeks of age were used in most 
experiments. AnimaIs to be made iron deficient were placed at 4 weeks on 
a diet containing 4-8 mg of iron/Kg, or alternatively were given an iron 
deficient diet at 6 weeks of age and bled 2-3 ml 4 to 5 times over two 
weeks to accelerate iron depletion. Female rats to be iron-Ioaded were 
placed on a 1% carbonyl iron diet for> 1 year with occasional 
reintroduction of a normal diet to maintain animaIs in good health. In 
order to suppress erythropoiesis, rats were transfused with 3 ml packed 
red cells approximately twice a week ta maintain an hematocrit of 60-65 %, 
and S9Fe ferritin was injected on the 5th day after the first transfusion. 
Hemolytic anemia was produced by the intraperitoneal injection of 50 mg 
acetylphenylhydrazine per Kg body weight, and S9Fe ferritin was injected 5 
days later. Inflammation was produced by injecting 0.25 ml turpentine oil 
in each thlgh, and 59Fe ferritin was injected 16 hours later. 
Plasma was drawn from a rat prepared in the sarne way as the experimental 
animaIs and labelled by adding 0.5 ~Ci S5Fe as FeS04 in 0.9% saline (pH 2) 
to 0.5 ml plasma. The rate of radioiron disappearance (t-1/2) was 




SeFe (~g/dl) x (100 - Ret x 0.92) x 7 
t-l/2 (min) 
Release of storage iron by the hepatocyte (i.e. late release) was studied 
over a peried of 14 days. The cumulative incorporation of S9Fe (injected 
as ferritin) and 5sFe (injected as diferric transferrin) in the red celi 
mass was determined over a 2 wk period. The ratio of 59Fe ta sSFe 
activity in the red cell mass at any tirne represents the total fraction of 
59Fe released by the hepatocyte (total release at time t = early release + 
late release at time t). When the complement of this ratio was plotted 
against time on a semilogarithmic paper, late release appeared ta be a 
single exponential curve. The proportion of the injected dose released in 
the early and late phases was obtained by extrapolating the curve ta zero 
tirne. The t-1/2 of the curve, determined by least squares, represents the 
speed of late release .and was expressed as % of the dose/day. Formal 
proof of this method has been published (5). Labelled compounds were 
injected into a tail vein and blood samples were obtained from the tail 
vein on the opposite side. At the end of each experiment, rats were 
exsanguinated from ~he abdominal aorta, and perfused with 20-30 ml saline. 
Whole blood, plasma, and liver activities were counted. Total plasma and 
total red cell activities were calculated from the hematocrit and assuming 
a blood volume of 0.07 ml/g body weight. Non-herne iron was extracted from 
rat livers and iron was determined by Proton-Induced X-ray Emission 
(PIXE). Assuming that ferritin s9Fe uniformly labelled non-heme iron 
stores in the hepatocyte, the amount of iron released daily by the hepatic 
parenchyma was calculated as the product of radioiron release (%/day) and 
hepatocyte iron stores (~g). 
Results 
Measurements of the PIT and late release are presented in table 1. 





































Normal males re!eased 17.5% of the ferritin s9Fe in the early phase. 
Thereafter, 6.3% of the residual hepatocyte radioiron was re!eased daily, 
representing a total of 207 ~g Fe/Kg/day, i.e. about 11% of the PIT. 
Normal fernales had a slower rate of late release. However, as their iron 
stores were consistently higher, the contribution of hepatocyte iron ta 
the PIT was found ta he higher than in males (21%). Iron turnover in the 
hepatocyte of iran deficient rats is extrernely rapid (56% ER and 
thereafter 17%/day of LR) but invalves relatively small amounts of iron, a 
little more than 10% of the PIT. By contrast, iron overloaded rats had a 
turnover about 10 times slower (6% ER and 1.6%/day of LR), amounting to a 
calculated value of 1584 ~g/kg/day, which is an overestimation. Rats 
treated with phenylhydrazine had an increased amount and rate af iron 
turnover in the hepatocyte. However, the participation of the parenchyrnal 
cell in the PIT was rather small (5%). On the other hand, hypertransfused 
rats had a slow turnover involving small amounts of iron which represented 
12% of the PIT. Inflammation reduced considerably the early release of 
radioiron. However, release of hepatocyte iron in the following days was 
normal. There was a very significant correlation between the percent ER 
and the rate of LR (R=0.90, P<O.OOl). Iron release was inversely related 
ta the hematocrit and positively to the PIT. Plasma iron and radioiron t-
1/2, as weIl as hepatic iron, correlated with the rate but not the 
absolute amount of iron release. 
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Discussion 
After uptake hy the hepatocyte, ferritin is catabolized and its iron 
enters an intermediate pool before being incorporated into stores (3,4). 
Because it i8 based on the assurnptions that ferritin 59Fe labels aIl 
hepatocyte iron stores uniformly and that aIl non-herne iron is mobilizable 
in the sarne way, the calculation of the amount of hepatocyte iron released 
daily ta the plasma i8 less precise than the measurement of radioiron 
release. The rate of radioiron re!ease was considerably increased in iron 
deficient rats but 6.2% of the ferritin 59Fe remained in the liver after 2 
wks, indicating that not aIl hepatic iron i8 rnobilizab!e by increased 
marrow requirements. Another pool of non-exchangeable iron, presumably 
hemosiderin, was identified in iron overloaded rats in which the 
calculation of iron released by the liver was grossly overestimated. In 
iron overload, hemosiderin iron represents a large proportion of hepatic 
iron, which is not exchangeable at least over the time and in the 
conditions of the present study. Nevertheless, the values obtained in 
non-deficient and non-overloaded rats are reasonable. Iron release in 
normal animaIs amounted to 207 ~g Fe/Kg/day, which represents 11.4% of the 
PIT. These findings are similar to values reported by others (4). This is 
also in accordance with hepatocyte iron uptake, as approxLffiately 10% of 
transferrin radioiron is localized in the liver after the early release 
phase. with iron deficient and iron overloaded rats not included in the 
analysis, there was a good correlation between hepatic storage iron and 
the rate of LR, but not with the absolute amount of iron released daily. 
This observation confirms that s9Fe and cold iron are released in a 
similar fashion. Inflammation produced a significant decrease in the rate 
of early radioiron release. However, late re1ease was not affected. 
These observations confirm a previous study in which the effect of 
turpentine-induced inflammation on storage iron mobilization was a1so 
transient and was no longer apparent beyond 48 hrs (6). However, human 
studies have shown that chronic inflammation is associated with a b10ckade 
of iron release from RE stores (7). The effect of erythropoiesis on 
547 
hepatocyte iron mobilization was examined in phenylhydrazine-injected and 
hypertransfused rats. Iron release was considerably modified in parallel 
ta changes in erythropoiesis. The amount of iron re!eased by the hepatic 
parenchyrna seemed appropriate (12% of the PIT) in hypertransfused rats. 
However, it accounted for only 4.9% of the PIT in phenylhydrazine-injected 
animaIs, indicating that recycling of red cell iron through the 
reticuloendothelial system contributed more than hepatocyte iron 
mobilization ta increased marrow iron requirements. 
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NEW DATA ON THE HYPOTHESIS OF THE BRAIN PARTICIPATION IN 
IRON HOMEOSTASIS 
B. Ribas, J.F. Pelayo, N. L. Roorigues. 
Institute of Biochemistry, CSIC-Complutense University, 
Faculty of Pharmacy, 28040-Madrid 
Abstract 
Ferropeni c posthemorrhagi c rats were used wh en hematocri te 
reached 30% and hemoglobin was lower than 8g/l00ml. The 
brain ;5 homogenized (1:4.w:v), sonicated, centrifuged and 
the supernatant, is incubated with 2pCi 59 Fe for a period 
of 20h. The subsequent elution of two peaks, supposedly 
ferritin and metallothionein marked with 59 Fe justifies 
the hypothesis before exposed of the brain participation 
in iran homeostasis. 
Introduction 
t·1etallothionein, a well known low relative molecular weight 
protein, with approximately 6000 D, 30% cystein and without 
aromatic aminoacid residues, associates between 5 ta 11 
atoms of metals (1,2). lts signification in metabolism is 
not well understood, it is suggested that it could participate 
as regulatory protein (3). Sorne data are published before, 
comparing the increase of transferrin and metallothionein 
in the intestinal mucosa of ferropenic rats ;n the brain 
(5,6) . 
The object of this work is to furnish new data which justify 
the hypothesis of the brain participation in ;ron homeostasis 
(7,8), exposed after the experimental results on the partici-
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